ABC Family Arquivos Brasileiros de Cardiologia International Journal of Cardiovascular Sciences ABC Heart Failure & Cardiomyopathy ABC Imagem Cardiovascular
Português English
ABC Family
Português English
  • About
    • About ABC Family
    • Internal Regulation
    • Editorial Board
    • Brazilian Society of Cardiology (SBC)
  • Issues
  • SBC Guidelines
  • Content
    • Videos
    • Podcasts
    • News
  • About
    • About ABC Family
    • Internal Regulation
    • Editorial Board
    • Brazilian Society of Cardiology (SBC)
  • Issues
  • SBC Guidelines
  • Content
    • Videos
    • Podcasts
    • News

ABC Family

  • ABC Family
  • Arquivos Brasileiros de Cardiologia
  • International Journal of Cardiovascular Sciences
  • ABC Heart Failure & Cardiomyopathy
  • ABC Imagem Cardiovascular
Search in

No content found.

Journals
Ordering
Article types
Others

  1. Home
  2. Keyword: von Willebrand factor
Total plasmatic homocysteine and von Willebrand factor in experimental diabetes mellitus
ABC
Artigo Original

Total plasmatic homocysteine and von Willebrand factor in experimental diabetes mellitus

Renato Delascio Lopes et al. Lindalva Batista Neves Vânia D'Almeida Gleice Margarete de Souza Conceição Alexandre Gabriel Junior

OBJECTIVES: To determine the plasma homocysteine and von Willebrand factor levels as markers of endothelial dysfunction in rats with diabetes mellitus induced by streptozotocin. METHODS: Thirty-five adult male rats (Rattus norvegicus albinus) (weight between 180-200g) were randomized into three groups: control group (n=10), which received no drugs or vehicles; sham group (n=10), which received streptozotocin solution; and diabetic group (n=15), which received streptozotocin. Eight weeks after diabetes mellitus induction, the animals were weighed and anesthesized; blood samples were collected from abdominal aorta for plasma total homocysteine, von Willebrand factor and glucose levels. RESULTS: The experimental model was reproducible in 100% of animals. The mean plasma homocysteine levels were: 7.9 µmol/l (control), 8.6µmol/l (sham) and 6.1µmol/l (diabetic), with difference among the groups (p<0.01). Multiple comparison analysis among the groups showed that values in the diabetic group were lower than in the sham group (p<0.01). The mean von Willebrand factor values were 0.15 U/l (control), 0.16U/l (sham) and 0.18 U/l (diabetic), with difference among the groups (p=0.03). The mean value was higher in the diabetic group than in the control group (p<0.05). Correlation between homocysteine and von Willebrand factor was not observed in the diabetic group. CONCLUSION: Reduced homocysteine levels and increased von Willebrand factor levels were observed in diabetes mellitus induced by streptozotocin; nevertheless, there were no correlations between them and with final glucose levels.

  • Diabetes Mellitus
  • Epidemiology
  • Experimental
  • homocysteine
  • von Willebrand factor
Read Full Article
Creative Commons Attribution (CC BY) Creative Commons license
24/05/2007 DOI: 10.1590/S0066-782X2007000400010 Views 2
ABC
Artigo Original

von Willebrand factor and pulmonary vascular endothelial cell dysfunction. Prognostic implications

Antonio Augusto B. Lopes et al. Nair Yukie Maeda Sérgio Paulo Bydlowski

PURPOSE: To analyze quantitative and structural changes in circulating von Willebrand factor (vWF) in 40 precapillary pulmonary hypertensive patients, as an attempt to identify possible correlations between endothelial cell dysfunction and patient short-term (one year) survival. METHODS: Plasma antigenic activity of vWF (vWF:Ag) was analyzed by immunoelectrophoresis. The relative concentration of vWF low molecular weight multimers (LMWM%) and the composition of vWF subunit were determined by densitometric analysis of Western blots. RESULTS: vWF:Ag was importantly increased in patients in comparison with normals (p<0.001). Patients also had increased LMWM% (p<0.001) and increased degradation of vWF main subunit (p<0.05). At the beginning of the study, nonsurvivors (N=11) had higher vWF:Ag (p<0.001) and LMWM% (p<0.005) values in comparison with survivors. LMWM% was selected by logistic regression analysis as a predictor of death during the first year of follow-up (p<0.05). CONCLUSION: Marked changes in circulating vWF likely reflect extensive pulmonary vascular endothelial cell dysfunction and are associated with poor short-term prognosis in pulmonary hypertension.

  • endothelial cell
  • Pulmonary Hypertension
  • von Willebrand factor
Read Full Article
Creative Commons Attribution (CC BY) Creative Commons license
08/01/2002 DOI: 10.1590/S0066-782X1998000300001 Views 1

How to cite this article

EndNote RIS

Electronic Document Format (Vancouver)

Lopes RD, Neves LB, D’Almeida V, Conceição GMS, Gabriel Junior A. Total plasmatic homocysteine and von Willebrand factor in experimental diabetes mellitus. Arquivos Brasileiros de Cardiologia 2007;88(4):424-9.

Electronic Document Format (ABNT)

Lopes, Renato Delascio; Neves, Lindalva Batista; D’Almeida, Vânia; Conceição, Gleice Margarete de Souza; Gabriel Junior, Alexandre. Total plasmatic homocysteine and von Willebrand factor in experimental diabetes mellitus. Arquivos Brasileiros de Cardiologia, v. 88, n. 4, p. 424-429, May. 2007.

Electronic Document Format (APA)

Lopes, R. D., Neves, L. B., D’Almeida, V., Conceição, G. M. S., & Gabriel Junior, A. (2007). Total plasmatic homocysteine and von Willebrand factor in experimental diabetes mellitus. Arquivos Brasileiros de Cardiologia, 88(4), 424-429.

Electronic Document Format (ISO)

Lopes, Renato Delascio and Neves, Lindalva Batista and D’Almeida, Vânia and Conceição, Gleice Margarete de Souza and Gabriel Junior, Alexandre. Total plasmatic homocysteine and von Willebrand factor in experimental diabetes mellitus. Arquivos Brasileiros de Cardiologia [online]. 2007, vol. 88, n. 4, [cited 2026-10-14], pp. 424-429. Available from: <https://journals.cardiol.br/en/article/total-plasmatic-homocysteine-and-von-willebrand-factor-in-experimental-diabetes-mellitus/>. ISSN 0066-782X

EndNote RIS

Electronic Document Format (Vancouver)

Lopes AAB, Maeda NY, Bydlowski SP. von Willebrand factor and pulmonary vascular endothelial cell dysfunction. Prognostic implications. Arquivos Brasileiros de Cardiologia 2002;70(3):141-5.

Electronic Document Format (ABNT)

Lopes, Antonio Augusto B.; Maeda, Nair Yukie; Bydlowski, Sérgio Paulo. von Willebrand factor and pulmonary vascular endothelial cell dysfunction. Prognostic implications. Arquivos Brasileiros de Cardiologia, v. 70, n. 3, p. 141-145, Jan. 2002.

Electronic Document Format (APA)

Lopes, A. A. B., Maeda, N. Y., & Bydlowski, S. P. (2002). von Willebrand factor and pulmonary vascular endothelial cell dysfunction. Prognostic implications. Arquivos Brasileiros de Cardiologia, 70(3), 141-145.

Electronic Document Format (ISO)

Lopes, Antonio Augusto B. and Maeda, Nair Yukie and Bydlowski, Sérgio Paulo. von Willebrand factor and pulmonary vascular endothelial cell dysfunction. Prognostic implications. Arquivos Brasileiros de Cardiologia [online]. 2002, vol. 70, n. 3, [cited 2026-10-14], pp. 141-145. Available from: <https://journals.cardiol.br/en/article/von-willebrand-factor-and-pulmonary-vascular-endothelial-cell-dysfunction-prognostic-implications/>. ISSN 0066-782X

  • About ABC Family
  • Internal Regulation
  • Editorial Board
  • Brazilian Society of Cardiology (SBC)

Issues

SBC Guidelines

  • Videos
  • Podcasts
  • News